51³ΙΘΛΆ―Βώ

Meeting Coverage

AAO

American Academy of Ophthalmology

Approval of Bevacizumab Biosimilar for Ophthalmic Use Could Upend Low-Cost Anti-VEGF

Provision in drug act would prohibit repackaging Avastin, add millions to anti-VEGF therapy cost

AAO over a photo of McCormick Place in Chicago, IL.

Latest AAO Meeting Coverage

Evidence of Durable Vision Improvement With Gene Therapy for Retinitis Pigmentosa

Significant improvement beyond 100 weeks after single injection of mutation-agnostic MCO-010

October 22, 2024
Laser Trabeculoplasty Tops Eye Drops as Frontline Treatment for Glaucoma

Office procedure reduced visual field loss by 29% over 6 years versus eye drops

October 22, 2024
New Strategies for Geographic Atrophy Show Early Promise

Drug targeting junctional zone reduces GA growth by 48% in 3 months, oral agent moderately active

October 21, 2024
Potentially Large Cost Savings With Home-Based OCT for Neovascular AMD

Study suggests potential to eliminate a third of in-office visits without harming care

October 21, 2024
Cataract Surgery Linked With Fewer Falls, Traumatic Injuries in Older Patients

Study adds leg and ankle fractures, intracranial hemorrhage to evidence on falls, hip fracture

October 20, 2024
Retinal Injections May Increase Risk for Cataract Surgery Complications

History of injections tied to multiple postop complications, but data open to questioning

October 20, 2024
At-Home Monitoring for Age-Related Macular Degeneration Gets High Marks

No change in visual acuity, office-visit interval almost doubled during 6 months

November 10, 2023
Ocular Implant Producing Neurotrophic Factor Preserves Central Vision in MacTel

Significant decrease in rate of photoreceptor loss in two randomized trials

November 8, 2023
Neuroprotective Agent Prevents Significant Vision Loss in Geographic Atrophy

Consistent vision effect with complement C1q inhibitor, despite no effect on lesion size

November 7, 2023
VEGF-Targeted Antibody Conjugate Gets a Win in Nonproliferative Diabetic Retinopathy

Some degree of improvement in disease status in 70% of patients treated with tarcocimab

November 6, 2023
Gene Therapy Controls Diabetic Eye Disease for at Least a Year

All but one patient with nonproliferative diabetic retinopathy had stable disease or improvement

November 6, 2023
Eye Drops Make Bid for Role in Diabetic Macular Edema

Improved visual acuity, retinal thickness at 6 and 12 weeks, but treatment burden questioned

November 5, 2023
AAO Roundup: Glaucoma Subtype Linked to Alzheimer's Disease Risk

Other studies report fewer reoperations with combo eye surgery and vision risk with shingles

October 6, 2022
Anti-VEGF Conjugate Gets a Win in Retinal Vein Occlusion

Tarcocimab noninferior to aflibercept while cutting treatment burden in half

October 4, 2022

Videos

AAO Video Pearls
November 2024